BEAM conditioning is well-tolerated and yields similar survival in obese and non-obese patients with lymphoma: no requirement for weight-based dose modifications

Bone Marrow Transplant. 2017 Mar;52(3):491-493. doi: 10.1038/bmt.2016.316. Epub 2017 Jan 9.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Allografts
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Carmustine / administration & dosage
  • Carmustine / adverse effects
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Lymphoma / mortality*
  • Lymphoma / therapy*
  • Male
  • Melphalan / administration & dosage
  • Melphalan / adverse effects
  • Middle Aged
  • Obesity*
  • Podophyllotoxin / administration & dosage
  • Podophyllotoxin / adverse effects
  • Prospective Studies
  • Transplantation Conditioning*

Substances

  • Cytarabine
  • Podophyllotoxin
  • Melphalan
  • Carmustine

Supplementary concepts

  • BEAM protocol